HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/4/L847    most recent 00216.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Kaneko, Y. Articles by Kohno, S. Search for Related Content PubMed PubMed Citation Articles by Kaneko, Y. Articles by Kohno, S.

Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis

¹The Second Department of Internal Medicine, Nagasaki University School of Medicine; and ²Department of Molecular Microbiology and Immunology, Division of Molecular and Clinical Microbiology, Nagasaki University Graduate School of Medical Sciences, Nagasaki 852-8501, Japan

Submitted 8 July 2002 ; accepted in final form 29 May 2003

Long-term treatment of macrolide antibiotics is considered an effective treatment for diffuse panbronchiolitis (DPB). Although hypersecretion is a common feature of this disease, and it is known that macrolides inhibit mucin production, the mechanism of the effect on mucin production is unclear. The aim of our study was to determine the production of muc5ac core protein, a major core protein of mucin in airway secretion, and the effect of clarithromycin treatment on such production in a mouse model mimicking DPB. Alcian blue-periodic acid-Schiff-positive cells were detected in the lungs of Pseudomonas aeruginosa-infected mice. Western blots of these mice showed muc5ac glycoprotein at day 1 and increased progressively from day 4 to day 14 after inoculation of bacteria. Clarithromycin (10 mg · kg^-1 · day^-1 for 7 days) significantly reduced the muc5ac expression at both the mRNA and protein levels. To investigate the role of molecules upstream in muc5ac regulation, we examined the role of mitogen-activated protein kinase. Extracellular signal-regulated kinase 1/2 phosphorylation increased in the infected lung and decreased after treatment. Our results suggest that overproduction of muc5ac plays an important role in the pathogenesis of DPB and that clinical improvement following macrolide therapy seems to involve, at least in part, its inhibition of mucin overproduction, through modulation of intracellular signal transduction.

macrolide; Pseudomonas aeruginosa

This article has been cited by other articles:

				Y. Nakanishi, D. Kobayashi, Y. Asano, T. Sakurai, M. Kashimura, S. Okuyama, Y. Yoneda, S. D. Shapiro, and K. Takayama Clarithromycin Prevents Smoke-induced Emphysema in Mice Am. J. Respir. Crit. Care Med., February 15, 2009; 179(4): 271 - 278. [Abstract] [Full Text] [PDF]

				H. Ishimoto, H. Mukae, N. Sakamoto, M. Amenomori, T. Kitazaki, Y. Imamura, H. Fujita, H. Ishii, S. Nakayama, K. Yanagihara, et al. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin J. Antimicrob. Chemother., January 1, 2009; 63(1): 109 - 114. [Abstract] [Full Text] [PDF]

				K. Rousseau, S. Kirkham, S. McKane, R. Newton, P. Clegg, and D. J. Thornton Muc5b and Muc5ac are the major oligomeric mucins in equine airway mucus Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1396 - L1404. [Abstract] [Full Text] [PDF]

				Y. Imamura, K. Yanagihara, Y. Fukuda, Y. Kaneko, M. Seki, K. Izumikawa, Y. Miyazaki, Y. Hirakata, T. Sawa, J. P. Wiener-Kronish, et al. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Eur. Respir. J., May 1, 2007; 29(5): 965 - 968. [Abstract] [Full Text] [PDF]

				V. Poletti, G. Casoni, M. Chilosi, and M. Zompatori Diffuse panbronchiolitis Eur. Respir. J., October 1, 2006; 28(4): 862 - 871. [Abstract] [Full Text] [PDF]

				M. Shinkai, J. Tamaoki, H. Kobayashi, S. Kanoh, K. Motoyoshi, T. Kute, and B. K. Rubin Clarithromycin Delays Progression of Bronchial Epithelial Cells from G1 Phase to S Phase and Delays Cell Growth via Extracellular Signal-Regulated Protein Kinase Suppression. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1738 - 1744. [Abstract] [Full Text] [PDF]

				M. Shinkai, G. H. Foster, and B. K. Rubin Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L75 - L85. [Abstract] [Full Text] [PDF]

				Y. Imamura, K. Yanagihara, K. Tomono, H. Ohno, Y. Higashiyama, Y. Miyazaki, Y. Hirakata, Y. Mizuta, J.-i. Kadota, K. Tsukamoto, et al. Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infection J. Med. Microbiol., June 1, 2005; 54(6): 515 - 518. [Abstract] [Full Text] [PDF]

				W. C. Tsai, M. L. Rodriguez, K. S. Young, J. C. Deng, V. J. Thannickal, K. Tateda, M. B. Hershenson, and T. J. Standiford Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1331 - 1339. [Abstract] [Full Text] [PDF]

				Y. Imamura, K. Yanagihara, Y. Mizuta, M. Seki, H. Ohno, Y. Higashiyama, Y. Miyazaki, K. Tsukamoto, Y. Hirakata, K. Tomono, et al. Azithromycin Inhibits MUC5AC Production Induced by the Pseudomonas aeruginosa Autoinducer N-(3-Oxododecanoyl) Homoserine Lactone in NCI-H292 Cells Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3457 - 3461. [Abstract] [Full Text] [PDF]